Results 111 to 120 of about 15,191 (179)

Targeting distinct amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas. [PDF]

Acta Neuropathol Commun
Ohba S, Hirayama A, Teranishi T, Hitachi K, Yamaguchi H, Murayama K, Natsumeda M, Tateishi K, Tsuchida K, Wakimoto H, Saya H, Pieper R, Hirose Y.   +12 more
europepmc   +1 more source

Characterization and bioactivities of glutaminase-free L-asparaginase from Salinicola acorporae S4-41. [PDF]

Microb Cell Fact
El-Shanshoury AER, Abosamra HH, Elsakhawy T.   +2 more
europepmc   +1 more source

Relapse risk and outcome of discontinuing asparaginase in children with acute lymphoblastic leukemia. [PDF]

Ann Hematol
Wang X, Liu C, Chen Y, Wang J, Wan Y, An W, Li X, Liu L, Liu F, Hu T, Zhang Y, Zhang L, Zou Y, Chen X, Chen Y, Guo Y, Zhu X, Yang W.   +17 more
europepmc   +1 more source

Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood: A Case Series. [PDF]

Pediatr Blood Cancer
Zarrabi M, Cahaney C, Schwartz LF, Kovach AE, Lin C, Stokke J.   +5 more
europepmc   +1 more source

Enzymatic properties of a L-asparaginase without secondary glutaminase activity from Streptomyces scabrisporus. [PDF]

PLoS One
Rodríguez-Vargas R, Villanueva-Flores F, Gutiérrez-Chávez MF, Medrano-Villagómez C, Zárate-Romero A, Huerta-Saquero A.   +5 more
europepmc   +1 more source

Aggressive Natural Killer Cell Leukemia: A Rare and Rapidly Progressive Hematologic Malignancy-Case Report and Literature Review. [PDF]

Case Rep Hematol
Priessnitz J, Hariri A, Levkiavska Y, Bonner KE, Fisher SI, Sill JM.   +5 more
europepmc   +1 more source

Chemosensitizing effect of apigenin on T-ALL cell therapy. [PDF]

Front Pharmacol
Huseynova N, Baran Z, Khalilov R, Mammadova A, Baran Y.   +4 more
europepmc   +1 more source

A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion. [PDF]

Front Oncol
Majid D, Wang Z, Schalk AM, Yuan B, Tatarata QZ, Root JL, Garza AI, Yassouf MY, Gamal BT, Feri-Borgogno S, Nguyen AH, Konopleva M, Peeters E, Su Y, Reville PK, Ravandi-Kashani F, Lavie A, Abbas HA.   +17 more
europepmc   +1 more source

Targeting asparagine potentiates anti-PD-L1 immunotherapy in gastric cancer by enhancing CD8⁺ T cell anti-tumor response. [PDF]

Front Immunol
Ge M, Wang L, Zheng B, Zhan L, Cui L, Wang H, Huang E, Xu Y, Chang X, Liu Z, Xu J, Yin K.   +11 more
europepmc   +1 more source

Optimizing Asparaginase Treatment for Adolescent and Young Adult (AYA) Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations. [PDF]

Am J Hematol
Aldoss I, Ali A, Cassaday RD, Curran EK, Luskin MR, Maese LD, Orgel E, Douer D.   +7 more
europepmc   +1 more source